Prolonging the lives of African-Americans with metastatic breast cancer by adding palbociclib to an aromatase inhibitor in routine clinical practice: a plain language summary of a real-world database study.
African American
metastatic breast cancer
palbociclib
real-world study
Journal
Future oncology (London, England)
ISSN: 1744-8301
Titre abrégé: Future Oncol
Pays: England
ID NLM: 101256629
Informations de publication
Date de publication:
22 Mar 2024
22 Mar 2024
Historique:
medline:
22
3
2024
pubmed:
22
3
2024
entrez:
22
3
2024
Statut:
aheadofprint
Résumé
This study used These results support the use of palbociclib with an AI as a first treatment for African-Americans with HR+/HER2- MBC.
Identifiants
pubmed: 38517416
doi: 10.2217/fon-2023-1079
doi:
Banques de données
ClinicalTrials.gov
['NCT05361655']
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM